{"transactions":[{"id":962576,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":71140,"kind":"person","name":"Ghias Babar","position":1,"cik":"0002076862","reported_name":"Ghias Babar","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-12-19T21:11:18.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":355050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":355050,"derivative":{"exercise_price":7.13,"exercise_date":"2026-12-17","expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":355050},"source":{"system":"sec-edgar","filing":"0000882796-25-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000038/form4.xml","form_type":"4"}},{"id":962575,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":71140,"kind":"person","name":"Ghias Babar","position":1,"cik":"0002076862","reported_name":"Ghias Babar","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:11:18.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":121700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":268700,"source":{"system":"sec-edgar","filing":"0000882796-25-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000088279625000038/form4.xml","form_type":"4"}},{"id":1081020,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":71140,"kind":"person","name":"Ghias Babar","position":1,"cik":"0002076862","reported_name":"Ghias Babar","relationship":{"officer":true,"officer_title":"CFO & Head of Corp Development"}}],"security":"Emp. Stock Option (Right to Buy)","published_at":"2025-07-28T20:09:44.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":305000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":305000,"derivative":{"exercise_price":8.55,"exercise_date":"2026-07-24","expiration_date":"2035-07-24","underlying":"Common Stock","underlying_shares":305000},"source":{"system":"sec-edgar","filing":"0001127602-25-019632","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225019632/form4.xml","form_type":"4"}},{"id":1081019,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":71140,"kind":"person","name":"Ghias Babar","position":1,"cik":"0002076862","reported_name":"Ghias Babar","relationship":{"officer":true,"officer_title":"CFO & Head of Corp Development"}}],"security":"Common Stock","published_at":"2025-07-28T20:09:44.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":147000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the \"Stock Incentive Plan\"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant."}],"balance_after":147000,"source":{"system":"sec-edgar","filing":"0001127602-25-019632","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760225019632/form4.xml","form_type":"4"}}]}